Predictions
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.80
03.04.23
03.04.23
-
03.04.27
03.04.27
-12.14%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.36
05.03.23
05.03.23
-
05.03.24
05.03.24
-35.75%
06.03.24
06.03.24
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.36
26.02.23
26.02.23
-
26.02.24
26.02.24
-35.75%
27.02.24
27.02.24
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.50
15.02.24
15.02.24
-
15.02.25
15.02.25
-3.09%
17.02.24
17.02.24
Risky Investment
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.20
25.12.23
25.12.23
€13.00
25.12.24
25.12.24
-2.27%
04.02.24
04.02.24
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€1.89
20.01.24
20.01.24
€1.00
20.01.25
20.01.25
-14.81%
03.02.24
03.02.24
Growpros Cannabis Ventures Inc
Start price
Target price
Perf. (%)
€0.012
15.01.23
15.01.23
€0.15
15.01.24
15.01.24
4.17%
16.01.24
16.01.24
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.20
24.12.23
24.12.23
-
24.12.24
24.12.24
1.36%
06.01.24
06.01.24
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.03
08.07.23
08.07.23
-
08.07.24
08.07.24
-18.91%
26.11.23
26.11.23
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.80
19.11.22
19.11.22
€2.00
19.11.23
19.11.23
-41.00%
20.11.23
20.11.23
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.88
16.11.22
16.11.22
-
16.11.23
16.11.23
-90.21%
17.11.23
17.11.23
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.40
24.10.23
24.10.23
-
24.10.24
24.10.24
-62.14%
28.10.23
28.10.23
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.23
17.09.23
17.09.23
-
17.09.24
17.09.24
-11.30%
02.10.23
02.10.23
Could be very worthwhile Investment >20% year
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.00
19.05.23
19.05.23
€2.20
19.05.24
19.05.24
-63.20%
01.10.23
01.10.23
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.85
03.09.23
03.09.23
-
03.09.24
03.09.24
-7.01%
16.09.23
16.09.23
Could be worthwhile Investment >10% per year
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€1.76
22.08.23
22.08.23
-
22.09.23
22.09.23
11.36%
04.09.23
04.09.23
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.98
21.08.23
21.08.23
-
21.08.24
21.08.24
-1.45%
02.09.23
02.09.23
Could be very worthwhile Investment >20% year
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€1.87
22.08.23
22.08.23
-
22.08.24
22.08.24
4.81%
02.09.23
02.09.23
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€1.70
22.08.23
22.08.23
-
22.08.24
22.08.24
15.29%
01.09.23
01.09.23
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.60
02.05.23
02.05.23
€12.00
02.05.24
02.05.24
-20.19%
27.08.23
27.08.23
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.08
07.08.23
07.08.23
-
07.08.24
07.08.24
-1.10%
19.08.23
19.08.23
Risky Investment
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.96
28.07.23
28.07.23
-
28.07.24
28.07.24
-8.84%
05.08.23
05.08.23